Last reviewed · How we verify

NCT03684330

Vitamin D Supplementation and WBV in Inflammatory Markers, Strength and Body Composition in Old Patients With COPD

Status unknown NA Last updated 25 September 2018
What this trial tests

NA trial testing Vitamin D in COPD in 59 participants. Status unknown.

Timeline
20 May 2018
Primary endpoint
30 August 2018
30 September 2018

Quick facts

Lead sponsorMaíra F Pessoa
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment59
Start date20 May 2018
Primary completion30 August 2018
Estimated completion30 September 2018
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Maíra F Pessoa

Who can join

Adults 60 to 75, any sex, with COPD or Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Verify the influence off vitamin D supplementation and a whole body vibration (WBV) protocol during 03 months in older patients chronic obstructive pulmonary disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Vitamin D

Trials testing the same drug.

Other recruiting trials for COPD

Currently open trials in the same condition.

Other Maíra F Pessoa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03684330.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing